Final Overall Survival Os Results from a Phase Iii, Randomised, Open-Label , First-Line Study of Gefitinib G V Carboplatin/Paclitaxel C/P in Clinically Selected Patients with Advanced Non-Small Cell Lung Cancer Nsclc in Asia Ipass
Resource
ANNALS OF ONCOLOGY v.21 SUPPL. 8 pp.1-2
Journal
ANNALS OF ONCOLOGY
Journal Volume
v.21
Journal Issue
8
Pages
1-2
Date Issued
2010
Date
2010
Author(s)
YANG, CHIH-HSIN
SDGs